1. Home
  2. Disease & Disorders
  3. Glenview, IL
  4. Society for Hematopathology

Society for Hematopathology

Society for Hematopathology has an America's Best Score of 59 out of 100, based on its 2026 Form 990, below the 60-point bar to be ranked.

  • Glenview, IL
  • Tax-exempt since 2009
  • EIN: 62-1114907
society-for-hematopathology.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
59OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Society for Hematopathology is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G90). Contributions are tax-deductible.

2111 Chestnut Ave Ste 145, Glenview, IL 60025-1609

Among the 4 scored disease & disorders organizations in Glenview, Society for Hematopathology holds 3.6 months of operating reserves (peer median 4.1 months), runs a typical yearly deficit of 30.0% (peers: deficit of 3.8%), and has grown spending 76.4% a year (peers: grown spending 38.0% a year).

In fiscal year 2026 it reported $590,594 in revenue and $773,571 in expenses, with contributions making up 31.5% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2026 Form 990

Stimulate interest, research, exchange of information and dissemination of knowledge concerning the biology, diagnosis and clinical aspects of the hematopoietic and lymphoreticular systems.

Largest programs · fiscal year 2026

  • Provided World Health Organization restricted funds received in prior years of $276,000 plus an additional $103,532 received this year to the Unicersity of Chicago. $379,532 spent · 52.4% of program spending
  • Co-sponsored the 2025 SH-EAHP Workshop on the malignancies and reactive disorders encountered in children, adolescents and young adults (AYA), many of which present preferentially or exclusively in this age group. It is the first SH-EAHP workshop in 22 years to focus on the hematopathologic disorders of this patient population. A major emphasis of the Workshop was to highlight advances in our unde… Read more

    Co-sponsored the 2025 SH-EAHP Workshop on the malignancies and reactive disorders encountered in children, adolescents and young adults (AYA), many of which present preferentially or exclusively in this age group. It is the first SH-EAHP workshop in 22 years to focus on the hematopathologic disorders of this patient population. A major emphasis of the Workshop was to highlight advances in our understanding of the molecular pathogenesis, particularly as they relate to the diagnosis, prognostication and clinical treatment of these disorders and the post-therapy detection of measurable residual disease using flow cytometric and next-generation sequencing-based molecular approaches. There were more than 400 attendees from approximately 30 different countries in attendance. Also participated in the USCAP meeting.

    $333,793 spent · 46.1% of program spending
  • Maintained website for membership and interested individuals which included a "case of the quarter" as well as video tutorials and other education related materials for professionals to review. Also, includes a "Virtual Curriculum" which is a series of lectures designed to provide hematopathology educational resources to pathology trainees affected by the COVID-19 pandemic. The lectures cover rele… Read more

    Maintained website for membership and interested individuals which included a "case of the quarter" as well as video tutorials and other education related materials for professionals to review. Also, includes a "Virtual Curriculum" which is a series of lectures designed to provide hematopathology educational resources to pathology trainees affected by the COVID-19 pandemic. The lectures cover relevant topics in bone marrow, lymph node and spleen pathology.

    $11,174 spent · 1.5% of program spending

Where each dollar went · fiscal year 2026

Of every dollar it spent, 94¢ went to programs, 6¢ to management and 0¢ to fundraising.

  • Programs $724,499
  • Management $49,072
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score59 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves3.6 mo; 3.6 mo in cash2.5 / 25
Financial balance (median margin)−30.0%5 / 20
Transparency4 full 990s, latest TY202620 / 20
Program growth+76.4% / yr15 / 15
Track record17 years6.8 / 10
Debt load0.0% of assets10 / 10
Total59.3 → 59
Spending on programs
Not scored; America's Best needs 65%+
94%Meets

Compared with Glenview peers

MeasureThis organizationPeer median
Operating reserves3.6 mo4.1 mo
Typical margin−30.0%−3.8%
Spending growth+76.4% / yr+38.0% / yr
Debt load0.0%1.6%

Peers: the 4 Glenview disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$590,594Fiscal year 20262023: $63,63620232024: $475,71120242025: $89,29420252026: $590,5942026
Expenses$773,571Fiscal year 20262023: $141,02220232024: $409,37020242025: $140,14620252026: $773,5712026
Total assets$230,192Fiscal year 20262023: $516,43820232024: $464,02120242025: $554,95120252026: $230,1922026
Total liabilities$0Fiscal year 20262023: $118,75820232024: $020242025: $141,78220252026: $02026
Fiscal year ending June 2026
Revenue$590,594
Expenses$773,571
Net income−$182,977
Net assets$230,192

Notable sources of revenue

Percent of total revenue
Contributions$186,113
Program services$401,406
Investment income$0
Other (net)$3,075

Assets / debt

Total assets$230,192
Total liabilities$0
Net assets$230,192

Compensation

Not in our extract for this year.

Fiscal year ending June 2025
Revenue$89,294
Expenses$140,146
Net income−$50,852
Net assets$413,169

Notable sources of revenue

Percent of total revenue
Contributions$0
Program services$85,174
Investment income$0
Other (net)$4,120

Assets / debt

Total assets$554,951
Total liabilities$141,782
Net assets$413,169

Compensation

Not in our extract for this year.

Fiscal year ending June 2024
Revenue$475,711
Expenses$409,370
Net income$66,341
Net assets$464,021

Notable sources of revenue

Percent of total revenue
Contributions$103,195
Program services$359,039
Investment income$12,462
Other (net)$1,015

Assets / debt

Total assets$464,021
Total liabilities$0
Net assets$464,021

Compensation

Not in our extract for this year.

Fiscal year ending June 2023
Revenue$63,636
Expenses$141,022
Net income−$77,386
Net assets$397,680

Notable sources of revenue

Percent of total revenue
Contributions$750
Program services$62,886
Investment income$0
Other (net)$0

Assets / debt

Total assets$516,438
Total liabilities$118,758
Net assets$397,680

Compensation

Officers and key employees$0
Share of expenses0.0%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?